Survivin in cancerology: molecular aspects and therapeutic applications

被引:10
作者
Romagnoli, Mathilde [1 ]
Seveno, Celine [1 ]
Bataille, Regis [1 ]
Barille-Nion, Sophie [1 ]
机构
[1] Univ Nantes, INSERM, Dept Rech Cancerol, UMR 892, F-44093 Nantes, France
来源
M S-MEDECINE SCIENCES | 2008年 / 24卷 / 10期
关键词
D O I
10.1051/medsci/20082410821
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Discovered 10 years ago, survivin has a dual role in the smooth progress of mitosis and in apoptosis resistance. Survivin plays an important physiological role in development, but is absent in differentiated adult tissues. In contrast, aberrant survivin expression is found in most human cancers because of the activation of various signalling pathways. A complex survivin network appears to intersect multiple pathways in cell biology, related to several molecular partners and fine subcellular localizations. Based on its pro-oncogenic properties, basic and translational studies have shown a growing interest in survivin that has led to consider survivin as a prognostic marker and a promising target for anti-tumoral therapies.
引用
收藏
页码:821 / 827
页数:7
相关论文
共 54 条
[1]   Opinion - Survivin, cancer networks and pathway-directed drug discovery [J].
Altieri, Dario C. .
NATURE REVIEWS CANCER, 2008, 8 (01) :61-70
[2]   Targeted therapy by disabling crossroad signaling networks:: the survivin paradigm [J].
Altieri, DC .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (03) :478-482
[3]   A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].
Ambrosini, G ;
Adida, C ;
Altieri, DC .
NATURE MEDICINE, 1997, 3 (08) :917-921
[4]   Degradation of survivin by the x-linked inhibitor of apoptosis (XIAP)-XAF1 complex [J].
Arora, Vinay ;
Cheung, Herman H. ;
Plenchette, Stephanie ;
Micali, O. Cristina ;
Liston, Peter ;
Korneluk, Robert G. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (36) :26202-26209
[5]   Heat shock proteins as molecular chaperones [J].
Arrigo, AP .
M S-MEDECINE SCIENCES, 2005, 21 (6-7) :619-625
[6]   From oncogenes to mitotic regulators: a profound change in our view of the process of cancerous transformation [J].
Blanchard, JM .
M S-MEDECINE SCIENCES, 2003, 19 (02) :187-199
[7]   Regulation of mitochondrial Smac/DIABLO-selective release by survivin [J].
Ceballos-Cancino, G. ;
Espinosa, M. ;
Maldonado, V. ;
Melendez-Zajgla, J. .
ONCOGENE, 2007, 26 (54) :7569-7575
[8]   Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms [J].
Chakravarti, A ;
Zhai, GG ;
Zhang, M ;
Malhotra, R ;
Latham, DE ;
Delaney, MA ;
Robe, P ;
Nestler, U ;
Song, QH ;
Loeffler, J .
ONCOGENE, 2004, 23 (45) :7494-7506
[9]   Cancer-specific activation of the survivin promoter and its potential use in gene therapy [J].
Chen, JS ;
Liu, JC ;
Shen, L ;
Rau, KM ;
Kuo, HP ;
Li, YM ;
Shi, D ;
Lee, YC ;
Chang, KJ ;
Hung, MC .
CANCER GENE THERAPY, 2004, 11 (11) :740-747
[10]   Separating the anti-apoptotic and mitotic roles of survivin [J].
Colnaghi, Rita ;
Connell, Claire M. ;
Barrett, Rachel M. A. ;
Wheatley, Sally P. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (44) :33450-33456